WC
www.cnsr.co.kr
The startup develops anti-cancer drug cell therapy utilizing high percentages of human immune cells to generate reliable clinical efficacy data from cancer tissue-derived tumor models. This approach enables medical researchers to evaluate new drug candidates with improved safety and efficacy, addressing the need for more effective cancer treatments.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops anti-cancer drug cell therapy utilizing high percentages of human immune cells to generate reliable clinical efficacy data from cancer tissue-derived tumor models. This approach enables medical researchers to evaluate new drug candidates with improved safety and efficacy, addressing the need for more effective cancer treatments.